Related Experiment Video
Updated: Jun 26, 2025

08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.5K
Harnessing Graphdiyne for Selective Cu2+ Detection: A Promising Tool for Parkinson's Disease Diagnostics and
Jing Jiang1, Xu Wang1, Yongqi Bao1
1Department of Chemistry, Capital Normal University, Beijing 100048, China.
ACS Sensors
|May 16, 2024
Summary
Graphdiyne (GDY) enables highly selective copper ion (Cu2+) detection, crucial for diagnosing Parkinson's disease (PD). This advancement overcomes interference, offering a sensitive biomarker for neurological disease research.
Area of Science:
- Materials Science
- Electrochemistry
- Neuroscience
Background:
- Copper ions (Cu2+) are implicated in Parkinson's disease (PD) pathogenesis by accelerating α-synuclein fibril propagation.
- Accurate Cu2+ detection is vital for PD diagnosis, but is hindered by interfering substances with similar electrochemical properties.
Purpose of the Study:
- To develop a highly selective electrochemical sensor for Cu2+ detection using graphdiyne (GDY).
- To investigate the potential of Cu2+ as a biomarker in Parkinson's disease research.
Main Methods:
- Utilized graphdiyne (GDY), a novel carbon allotrope, for Cu2+ detection due to its strong electron-donating ability and adsorption capacity.
- Employed Density Functional Theory (DFT) calculations to understand the adsorption mechanism of Cu atoms on GDY.
- Developed a GDY-based electrochemical sensor to assess Cu2+ concentration in cellular models.
Main Results:
- DFT calculations confirmed GDY's cavity is favorable for Cu adsorption and electrochemical sensing, outperforming graphene (GR).
- The GDY sensor demonstrated high selectivity, avoiding interference from amino acids, metal ions, and neurotransmitters.
- Achieved high sensitivity (9.77 μA·μM-1·cm-2) with a low detection limit (200 nM).
- Observed changes in intracellular Cu2+ concentrations following L-DOPA and GSH treatments in cellular models.
Conclusions:
- GDY provides a superior platform for selective Cu2+ detection, enhancing specificity through favorable adsorption properties.
- Cu2+ shows significant potential as a biomarker for Parkinson's disease, aiding in understanding its pathogenesis and therapeutic processes.
- This work offers insights into the role of Cu2+ in neurobiology and neurological disorders.

